Skip to main content
Signal8

Ek John Frederick

SEC insider (Form 3/4/5 filer). CIK 0001767921. CFO at Akoya Biosciences, Inc. (AKYA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2025. Located in MARLBOROUGH, MA.

Companies Ek John Frederick has filed insider reports for

  • Akoya Biosciences, Inc. (AKYA): Officer, CFO
Ek John Frederick profile photo

Ek John Frederick

CIK: 0001767921

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)5 (83.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Akoya Biosciences, Inc. logo
AKYA

Akoya Biosciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Direct
    54.5K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Direct
    193.8K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Jul 8, 2025
    Other
    Indirect
    20K shares-
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Apr 1, 2025
    Tax Payment
    Direct
    16.4K shares at avg. $1.35$22K
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Mar 1, 2025
    Tax Payment
    Direct
    3.6K shares at avg. $1.63$6K
  • Akoya Biosciences, Inc. logo
    AKYA

    Akoya Biosciences, Inc.

    Nov 19, 2024
    Award
    Direct
    87.5K shares-

1-6 of 6